Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys.

Andersson E, Shao W, Bontell I, Cham F, Cuong do D, Wondwossen A, Morris L, Hunt G, Sönnerborg A, Bertagnolio S, Maldarelli F, Jordan MR.

Infect Genet Evol. 2013 Aug;18:125-31. doi: 10.1016/j.meegid.2013.03.050. Epub 2013 Apr 11.

2.
3.

Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.

Romero A, Sued O, Puig T, Esteve A, Pumarola T, Casabona J, González V, Matas L, Tural C, Rodrigo I, Margall N, Domingo P, Casanova A, Ferrer E, Caballero E, Ribera E, Farré J, Puig T, Amengual MJ, Navarro G, Prat JM, Masabeu A, Simó JM, Villaverde CA, Barrufet P, Sauca MG, Ortin X, Ortí A, Navarro R, Euras JM, Vilaró J, Villà MC, Montull S, Vilanova C, Pujol F, Díaz O, Miró JM; AERI study Group..

Enferm Infecc Microbiol Clin. 2011 Aug-Sep;29(7):482-9. doi: 10.1016/j.eimc.2011.03.001. Epub 2011 May 2.

PMID:
21543135
4.

Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies.

Meixenberger K, Hauser A, Jansen K, Yousef KP, Fiedler S, von Kleist M, Norley S, Somogyi S, Hamouda O, Bannert N, Bartmeyer B, Kücherer C.

J Clin Microbiol. 2014 Aug;52(8):2977-83. doi: 10.1128/JCM.03289-13. Epub 2014 Jun 11.

5.

A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.

Cousins MM, Konikoff J, Sabin D, Khaki L, Longosz AF, Laeyendecker O, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Kobin BA, Wheeler D, Justman JE, Hodder SL, Quinn TC, Brookmeyer R, Eshleman SH.

PLoS One. 2014 Jun 26;9(6):e101043. doi: 10.1371/journal.pone.0101043. eCollection 2014.

6.

Phylogenetic investigation of transmission pathways of drug-resistant HIV-1 utilizing pol sequences derived from resistance genotyping.

Kaye M, Chibo D, Birch C.

J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):9-16. doi: 10.1097/QAI.0b013e318180c8af.

PMID:
18667928
7.

Developing high-throughput HIV incidence assay with pyrosequencing platform.

Park SY, Goeken N, Lee HJ, Bolan R, Dubé MP, Lee HY.

J Virol. 2014 Mar;88(5):2977-90. doi: 10.1128/JVI.03128-13. Epub 2013 Dec 26.

8.

Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED.

Ragonnet-Cronin M, Aris-Brosou S, Joanisse I, Merks H, Vallée D, Caminiti K, Rekart M, Krajden M, Cook D, Kim J, Malloch L, Sandstrom P, Brooks J.

J Infect Dis. 2012 Sep 1;206(5):756-64. doi: 10.1093/infdis/jis411. Epub 2012 Jul 23.

PMID:
22826337
9.

Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon.

Pandrea I, Robertson DL, Onanga R, Gao F, Makuwa M, Ngari P, Bedjabaga I, Roques P, Simon F, Apetrei C.

AIDS Res Hum Retroviruses. 2002 Oct 10;18(15):1103-16.

PMID:
12396449
10.

Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.

Yaotsè DA, Nicole V, Roch NF, Mireille PD, Eric D, Martine P.

Infect Genet Evol. 2009 Jul;9(4):646-52. doi: 10.1016/j.meegid.2009.04.002. Epub 2009 Apr 15.

PMID:
19460333
11.

Molecular characterization of ambiguous mutations in HIV-1 polymerase gene: implications for monitoring HIV infection status and drug resistance.

Zheng DP, Rodrigues M, Bile E, Nguyen DB, Diallo K, DeVos JR, Nkengasong JN, Yang C.

PLoS One. 2013 Oct 17;8(10):e77649. doi: 10.1371/journal.pone.0077649. eCollection 2013.

12.

Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia.

Abegaz WE, Grossman Z, Wolday D, Ram D, Kaplan J, Sibide K, Wuhib T, Ismael S, Nkengasong J, Mekonen T, Berhanu H, Messele T, Lulseged S, Maayan S, Mengistu Y.

Antivir Ther. 2008;13 Suppl 2:89-94.

PMID:
18575196
13.

Genetic diversity of HIV-1 and transmitted drug resistance among newly diagnosed individuals with HIV infection in Hangzhou, China.

Zhang J, Guo Z, Yang J, Pan X, Jiang J, Ding X, Zhang W, Xia Y, Xu Y, Huang J.

J Med Virol. 2015 Oct;87(10):1668-76. doi: 10.1002/jmv.24223. Epub 2015 Apr 20.

PMID:
25899877
14.

Identification and distribution of HIV type 1 genetic diversity and protease inhibitor resistance-associated mutations in Shanghai, P. R. China.

Zhong P, Kang L, Pan Q, Konings F, Burda S, Ma L, Xue Y, Zheng X, Jin Z, Nyambi P.

J Acquir Immune Defic Syndr. 2003 Sep 1;34(1):91-101.

PMID:
14501800
15.

Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV type 1-infected, untreated patients in Hungary.

Mezei M, Ay E, Koroknai A, Tóth R, Balázs A, Bakos A, Gyori Z, Bánáti F, Marschalkó M, Kárpáti S, Minárovits J.

AIDS Res Hum Retroviruses. 2011 Nov;27(11):1243-7. doi: 10.1089/AID.2011.0077. Epub 2011 May 9.

PMID:
21453184
16.

Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.

Zhou Z, Wagar N, DeVos JR, Rottinghaus E, Diallo K, Nguyen DB, Bassey O, Ugbena R, Wadonda-Kabondo N, McConnell MS, Zulu I, Chilima B, Nkengasong J, Yang C.

PLoS One. 2011;6(11):e28184. doi: 10.1371/journal.pone.0028184. Epub 2011 Nov 23.

17.

Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America.

Murillo W, Lorenzana de Rivera I, Albert J, Guardado ME, Nieto AI, Paz-Bailey G.

J Med Virol. 2012 Oct;84(10):1514-21. doi: 10.1002/jmv.23381.

PMID:
22930496
18.

Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.

Couto-Fernandez JC, Silva-de-Jesus C, Veloso VG, Rachid M, Gracie RS, Chequer-Fernandez SL, Oliveira SM, Arakaki-Sanchez D, Chequer PJ, Morgado MG.

Mem Inst Oswaldo Cruz. 2005 Feb;100(1):73-8. Epub 2005 Apr 12.

19.

HIV genotypes and primary drug resistance among HIV-seropositive blood donors in Brazil: role of infected blood donors as sentinel populations for molecular surveillance of HIV.

Alencar CS, Sabino EC, Carvalho SM, Leao SC, Carneiro-Proietti AB, Capuani L, Oliveira CL, Carrick D, Birch RJ, Gonçalez TT, Keating S, Swanson PA, Hackett J Jr, Busch MP; NHLBI Retrovirus Epidemiology Donor Study-II (REDS-II), International Component..

J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):387-92. doi: 10.1097/QAI.0b013e31828ff979.

20.

Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.

de Mulder M, Yebra G, Martín L, Prieto L, Mellado MJ, Rojo P, Muñoz-Fernández MÁ, Jiménez de Ory S, Ramos JT, Holguín A; Madrid cohort of HIV-infected children..

J Antimicrob Chemother. 2011 Oct;66(10):2362-71. doi: 10.1093/jac/dkr305. Epub 2011 Aug 2.

PMID:
21810838

Supplemental Content

Support Center